Form 8-K - Current report:
SEC Accession No. 0001213900-13-006650
Filing Date
2013-11-18
Accepted
2013-11-18 14:23:56
Documents
4
Period of Report
2013-11-11
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k111113_actiniumpharma.htm 8-K 27744
2 ACTINIUM PHARMACEUTICALS, INC. WEBINAR TRANSCRIPT. f8k111113ex99i_actinium.htm EX-99.1 60394
3 ACTINIUM PHARMACEUTICALS, INC. PRESS RELEASE ISSUED NOVEMBER 18, 2013. f8k111113ex99ii_actinium.htm EX-99.2 21996
4 logo.jpg GRAPHIC 7031
  Complete submission text file 0001213900-13-006650.txt   121138
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52446 | Film No.: 131226548
SIC: 6770 Blank Checks